Login
Novartis AG logo

Novartis AG

novartis.com

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,267 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Financial Snapshot

Revenue
TTM
$56.67B
Gross Margin
TTM
74.94%
Net Income
TTM
$12.76B
Current Assets
2026 Q2
$27.35B
Current Liabilities
2026 Q2
$31.75B
Current Ratio
2026 Q2
86.15%
Total Assets
2026 Q2
$122.0B
Total Liabilities
2026 Q2
$80.49B
Book Value
2026 Q2
41.54B
Cash
2026 Q2
$7.616B
P/E
TTM
18.19
Free Cash Flow
TTM
$14.98B

Stock Price

Loading...
Market Cap: $232.08 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support